Therapeutic Indications

Cabergoline is indicated for:

Hyperprolactinaemia

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral

Inhibition of lactation procedure

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral

Contraindications

Active ingredient Cabergoline is contraindicated in the following cases:

No gender/age discrimination

at least one of
Unspecified adverse effect of drug or medicament


Phenothiazines with aliphatic side-chain

Phenothiazines with piperazine structure

Phenothiazines with piperidine structure

Butyrophenone derivatives

Thioxanthene derivatives

Metoclopramide

Macrolides

No gender/age discrimination

at least one of
Lactation

Pregnancy